Cytokinetics Inc (CYTK)
Operating profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | -536,248 | -496,205 | -324,202 | -186,313 | -93,943 |
| Revenue | US$ in thousands | 18,474 | 7,530 | 94,588 | 70,428 | 55,828 |
| Operating profit margin | -2,902.72% | -6,589.71% | -342.75% | -264.54% | -168.27% |
December 31, 2024 calculation
Operating profit margin = Operating income ÷ Revenue
= $-536,248K ÷ $18,474K
= -2,902.72%
The operating profit margin of Cytokinetics Inc has shown a significant decline over the years based on the provided data. In 2020, the operating profit margin was recorded at -168.27%, indicating that the company's operating expenses surpassed its operating income. This negative trend continued into 2021 and 2022, with operating profit margins of -264.54% and -342.75% respectively, reflecting the company's struggle to generate profits from its core business operations.
However, there was a drastic deterioration in the operating profit margin in 2023, plummeting to a staggering -6,589.71%. This sharp decline suggests severe inefficiencies or challenges within the company's operational structure, leading to a substantial loss relative to its operating revenue. Although there was an improvement in 2024, with the operating profit margin improving to -2,902.72%, the overall negative trend in the operating profit margin signals ongoing difficulties for Cytokinetics Inc in effectively managing its operating expenses and generating profits from its operations.
Peer comparison
Dec 31, 2024